Latest Industry Insights

Industry Insight
AI Is Redefining the Role of the Scientist – Here’s How
The integration of AI and automation is transforming laboratory research, improving overall efficiency and scalability. However, scientists must be cautious as over-reliance on AI may weaken critical thinking and troubleshooting skills.

Industry Insight
AI’s Next Horizon: Cell and Gene Therapy Manufacturing
Dalip Sethi provides valuable insights on how AI is currently being carefully and critically considered within the cell and gene therapy industry, with regard to data and technological preparedness.

Industry Insight
Overcoming CAR T-Cell Therapy Limitations
In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and innovative manufacturing strategies are overcoming the key limitations of autologous CAR T-cell therapy.

Industry Insight
Flow Cytometry Advancements Accelerate Drug Discovery
A specialist in flow cytometry, cell sorting and cellular biology, Dr. Richard Cuthbert shared his perspectives on the current and future applications of flow cytometry – and automated flow cytometry systems – in modern drug discovery.

Industry Insight
Bridging the Gap Between Stem Cell Therapy Research and Clinical Trials
Dr. Bo Wiinberg, chief business development officer at the Novo Nordisk Foundation Cellerator, discusses the current obstacles halting advances in stem cell-based cell therapies and what can be done to overcome them.

Industry Insight
T-Cell Priming Technology Strengthens Pandemic Preparedness
Technology Networks spoke to Professor Thomas Rademacher, co-founder, executive director and CEO at Gylden Pharma Limited, to learn more about T-cell priming vaccine technology and its potential to strengthen preparedness for future pandemics.

Industry Insight
Simplifying Cell Visualization in Complex Model Systems
bit.bio’s GFP ioMicroglia enables real-time tracking of microglia in complex co-cultures and in vivo, streamlining neurodegeneration research and drug discovery.

Industry Insight
Advancing Flow Cytometry With High-Throughput Analysis and Automation
Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.

Industry Insight
Tackling Rare Diseases With RNA Therapeutics
To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.

Industry Insight
Going Mobile in the Lab
Labs have been using "mobile devices" – paper and pencil – for centuries. Now it's time to embrace "modern" mobile devices.
Advertisement